ArticleBritish journal of cancer2022

MYB interacts with androgen receptor, sustains its ligand-independent activation and promotes castration resistance in prostate cancer.

Sanjeev Kumar Srivastava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.